Devin Geng is a China Associate in the Corporate practice of Paul Hastings. Mr. Geng’s primary focus is on equity and debt capital markets transactions as issuer’s counsel. In addition, he also advises clients on compliance related laws and regulatory matters involving the United States DOJ and SEC.
Mr. Geng is fluent in English and Mandarin, Chinese. Mr. Geng previously worked at a U.S. law firm in Atlanta, Georgia. He is admitted to the New York Bar.
Paul Hastings Continues HK Biotech IPO Spree with SinoMab BioScience’s Debut
November 12, 2019
Mei Nian Investment Issues US$200 Million Guaranteed Senior Notes
April 08, 2019